Bing Yan Selected Research

crotalid hemorrhagic factor B (NHFb)

5/2015	Improving both aqueous solubility and anti-cancer activity by assessing progressive lead optimization libraries.
8/2013	Anti-tumor selectivity of a novel tubulin and HSP90 dual-targeting inhibitor in non-small cell lung cancer models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bing Yan Research Topics

Disease

84	Neoplasms (Cancer) 01/2022 - 01/2006
16	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2007
13	Inflammation (Inflammations) 01/2021 - 01/2013
10	Stomach Neoplasms (Stomach Cancer) 10/2020 - 01/2013
8	Hepatocellular Carcinoma (Hepatoma) 09/2020 - 05/2013
7	Rhinosinusitis 05/2022 - 01/2019
7	Nasal Polyps (Nasal Polyp) 05/2022 - 01/2019
7	Breast Neoplasms (Breast Cancer) 03/2016 - 12/2007
6	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 06/2011
6	Infections 09/2021 - 06/2015
6	Lung Neoplasms (Lung Cancer) 04/2021 - 03/2008
6	Melanoma (Melanoma, Malignant) 01/2021 - 01/2016
6	Brain Death (Brain Dead) 01/2018 - 10/2014
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 09/2011
5	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2015
5	Prostatic Neoplasms (Prostate Cancer) 05/2018 - 10/2006
4	Obesity 01/2022 - 01/2013
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 11/2013
4	Ischemia 01/2022 - 01/2018
4	Reperfusion Injury 01/2022 - 01/2018
4	Congenital Abnormalities (Deformity) 10/2021 - 09/2016
4	Wounds and Injuries (Trauma) 01/2021 - 01/2016
4	Overweight 01/2021 - 01/2017
4	Pain (Aches) 01/2020 - 01/2016
4	Lymphatic Metastasis 09/2016 - 01/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2015 - 03/2008
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 01/2010
3	Myocardial Infarction 01/2021 - 01/2018
3	Necrosis 01/2021 - 05/2012
3	Dermatomyositis (Dermatopolymyositis) 01/2021 - 01/2018
3	Adenocarcinoma of Lung 01/2020 - 12/2018
3	Carcinoma (Carcinomatosis) 04/2019 - 01/2015
3	Hypersensitivity (Allergy) 12/2018 - 01/2016
3	Influenza in Birds (Avian Flu) 01/2017 - 01/2011
3	Tics (Tic) 01/2016 - 02/2014
3	Alzheimer Disease (Alzheimer's Disease) 02/2007 - 07/2003
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 12/2016
2	Adenoma (Adenomas) 10/2021 - 01/2018
2	Polyps 01/2021 - 01/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 04/2019
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 01/2018
2	Eosinophilia 07/2020 - 01/2020

Drug/Important Bio-Agent (IBA)

28	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2006
21	Pharmaceutical PreparationsIBA 08/2021 - 01/2006
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
10	Messenger RNA (mRNA)IBA 09/2020 - 08/2010
10	GoldIBA 02/2019 - 04/2011
9	CytokinesIBA 05/2022 - 06/2015
7	CopperIBA 10/2021 - 01/2007
7	Insulin (Novolin)FDA Link 01/2021 - 07/2016
7	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2011 - 12/2006
6	Paclitaxel (Taxol)FDA LinkGeneric 03/2018 - 01/2006
5	Phosphotransferases (Kinase)IBA 01/2022 - 03/2014
5	Carbon Nanotubes (Carbon Nanotube)IBA 12/2021 - 05/2009
5	CateninsIBA 10/2021 - 03/2016
5	Therapeutic UsesIBA 08/2021 - 01/2017
5	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 09/2016
5	Long Noncoding RNAIBA 10/2020 - 08/2014
5	EnzymesIBA 01/2020 - 01/2011
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 05/2012
5	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2014
5	Proteasome InhibitorsIBA 01/2019 - 12/2006
4	CarbonIBA 12/2021 - 07/2010
4	LigandsIBA 04/2021 - 04/2011
4	Caspase 3 (Caspase-3)IBA 10/2019 - 08/2010
4	LipidsIBA 01/2015 - 05/2011
3	IonsIBA 10/2021 - 08/2017
3	FlavonoidsIBA 01/2021 - 12/2006
3	Salivary CystatinsIBA 01/2021 - 01/2019
3	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 09/2020 - 01/2020
3	Monoclonal AntibodiesIBA 01/2020 - 01/2011
3	corydalmineIBA 01/2020 - 01/2017
3	Cytochromes c (Cytochrome c)IBA 01/2020 - 10/2014
3	IronIBA 01/2019 - 07/2010
3	Biological ProductsIBA 01/2019 - 12/2009
3	Histone Deacetylase 6IBA 01/2018 - 11/2013
3	Antiviral Agents (Antivirals)IBA 01/2017 - 10/2015
3	Triglycerides (Triacylglycerol)IBA 12/2016 - 01/2013
3	alpha-Tocopherol FDA Link 05/2015 - 02/2014
3	TubulinIBA 01/2015 - 08/2013
3	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 11/2008 - 07/2007
2	IntegrinsIBA 01/2022 - 01/2015
2	Carcinoembryonic AntigenIBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Small Interfering RNA (siRNA)IBA 09/2021 - 01/2016
2	lysolecithin acylhydrolaseIBA 01/2021 - 01/2020
2	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 01/2015
2	Interferon Type IIBA 01/2021 - 03/2015
2	Immune Checkpoint InhibitorsIBA 09/2020 - 12/2018

Therapy/Procedure

23	Therapeutics 01/2022 - 12/2006
13	Drug Therapy (Chemotherapy) 01/2022 - 12/2006
4	Radiotherapy 04/2022 - 08/2013
4	Acupuncture Points (Acupuncture Point) 11/2021 - 11/2019
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2021 - 01/2013
4	Immunotherapy 04/2021 - 01/2018
3	Vegetarian Diet (Vegetarianism) 01/2013 - 09/2011
2	Adjuvant Chemotherapy 06/2022 - 04/2019
2	Liver Transplantation 01/2022 - 01/2022
2	Electroacupuncture 11/2021 - 04/2008
2	Cystectomy 01/2021 - 04/2019